Image For Activity Cover
2018 Board Certification Review Course: AHFTC
General Meeting Information
The 2018 Board ReviewCourse content is based on the ABIM content blueprint for the certification examination in Advanced Heart Failure and Transplant Cardiology. This activity will use concise didactic presentations by national experts, case studies, and panel discussions. 

The following areas are addressed:
  • Epidemiology and Causes of Heart Failure
  • Pathophysiology of Heart Failure
  • Evaluation of Heart Failure Management of Hospitalized Patients
  • Management of Heart Failure
  • Comorbidities or Coexisting Conditions
  • Cardiac Surgery in Heart Failure
  • Heart Transplant
  • Mechanical Circulatory Support
  • Pulmonary Arterial Hypertension
  • Contemporary HF Management Topics
Intended Audience
2018 Board Certification Review Course: AHFTC is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and health care professionals who specialize or have an interest in heart failure.
Learning Objectives

Upon completion of the activity, participants will demonstrate improved competence and ability to:

For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:

  1. Identify gaps in knowledge about advanced heart failure and transplant cardiology
  2. Focus study efforts on filling identified knowledge gaps
  3. Practice for the certification examination with ABIM-style multiple-choice test questions

For Clinical Practice:

  1. Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure
  2. Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms
  3. Assess and follow the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers
  4. Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices
  5. Implement appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, or cardiorenal syndrome
  6. Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and depression
  7. Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care

Competencies

This HFSA Board Review Course has been designed based on the competencies identified with practice in the area of Advanced Heart Failure and Transplant Cardiology.

These competencies include epidemiology, causes and management of patients with HF, management of hospitalized patients, management of comorbidities, cardiac surgery in HF, medical management of the heart transplant patient and patients with mechanical circulatory support, and evaluation and management of patients with pulmonary arterial hypertension.

Faculty
Sean P. Pinney, MD (Program Chair)
Director, Heart Failure and Transplantation,
The Mount Sinai Health System
Director, Advanced HF and Transplantation Program
The Mount Sinai Hospital
New York, NY

Akshay Desai, MD, MPH, FHFSA (Program Chair)
Director of the Cardiomyopathy and HF Program
Brigham and Women’s Hospital
Associate Professor, Medicine
Harvard Medical School
Boston, MA

Allen S. Anderson, MD, FACC, FAHA
Professor of Medicine
Medical Director, Center for Heart Failure
Bluhm Cardiovascular Institute
Northwestern Medicine
Chicago, IL

Daniel Burkhoff, MD, PhD
Adjunct Associate Professor of Medicine, Columbia
University
New York, NY
Adjunct Clinical Professor of Internal Medicine, The
Ohio State University Medical Center
Columbus, OH

Javed Butler, MD, MPH, MBA, FHFSA
Professor and Chairman of the Department of
Medicine
University of Mississippi
Jackson, MS

Joshua M. Cooper, MD
Director, Cardiac Electrophysiology
Professor, Medicine
Temple University
Philadelphia, PA

Mark Drazner, MD, FHFSA
Medical Director of the Heart Failure, LVAD, and
Cardiac Transplantation Program
James M. Wooten Chair in Cardiology
Professor, Internal Medicine
University of Texas Southwestern Medical Center
Dallas, TX

James C. Fang, MD, FACC, FAHA, FHFSA
Professor of Medicine
Chief, Division of Cardiovascular Medicine
Executive Director, Cardiovascular Service Line
University of Utah
Salt Lake City, UT

G. Michael Felker, MD, FHFSA
Chief, Heart Failure Section
Professor of Medicine
Duke University School of Medicine
Durham, NC

Eric V. Krieger, MD
Associate Professor, Department of Medicine &
Division of Cardiology
Associate Director, UW Medicine’s Adult Congenital
Heart Disease Program
University of Washington Medical Center
Seattle, WA

Jon W. Lomasney, MD
Northwestern Medicine, Feinberg School of Medicine
Chicago, IL

Anju Nohria, MD, MSc
Assistant Professor of Medicine, Harvard Medical
School
Director, Brigham and Women’s Hospital/Dana Farber
Cancer Institute
Boston, MA

Jonathan D. Rich, MD, FHFSA
Associate Professor of Medicine
Northwestern University, Evanston, IL
Feinberg School of Medicine
Medical Director of the Mechanical Circulatory Support
Program
Program Director of the Advanced Heart Failure and
Transplant Fellowship Program,
Northwestern Memorial Hospital
Chicago, IL

Joseph G. Rogers, MD
Professor of Medicine
Interim Chief, Division of Cardiology
Vice Chair for Clinical Practice, Department of Internal
Medicine
Duke University School of Medicine
Durham, NC
 
Sanjiv J. Shah, MD
Professor of Medicine
Director, T1 Center for Cardiovascular Developmental Therapeutics
Director, Northwestern HFpEF Program
Division of Cardiology, Department of Medicine
Northwestern University Feinberg School of Medicine
Northwestern University
Chicago, IL

Nir Uriel, MD, MSc
Louis Block Professor in Medicine
Director, Heart Failure, Transplant and Mechanical Circulatory Support
University of Chicago Medicine
Chicago, IL

Lynne W. Stevenson, MD
Professor of Medicine
Program Director, Advanced Heart Failure Fellowship Program
Vanderbilt University
Nashville, TN
Course Description
  • Welcome and Introduction
  • Live ABIM Style Question Session - S. Pinney; A. Desai
  • Pathophysiology I: Cellular and Energetic Considerations - D. Burkhoff
  • Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations (PV Loops) - D. Burkhoff
  • Hemodynamics in Heart Failure I - J. Fang
  • Hemodynamics in Heart Failure II - J. Fang
  • Cardiomyopathies I: Ischemic and Valvular - J. Rogers
  • Cardiomyopathies II: Nonischemic and Peripartum - A. Desai
  • Cardiomyopathies III: HCM Amyloid and Infiltrative - A. Desai
  • Cardiomyopathies IV: ARVC and Inherited - A. Nohria
  • Cardio-Oncology - A.Nohria
  • Ambulatory Hemodynamic Monitoring/Remote Patient Monitoring - A. Desai
  • Pulmonary Hypertension - J. Rich
  • Q&A - Faculty
  • Live ABIM Style Question Session - S. Pinney; A. Desai
  • Advanced Heart Failure: Defining the Phenotype and Patient Selection - A. Anderson
  • Immunology: The Basics, PRA, Sensitization, Crossmatch - S. Pinney
  • Rejection: Cellular and Antibody Mediated - S. Pinney
  • Managing Immunosuppression and Drugs - J. Fang
  • Heart Transplant, Clinical Outcomes and Complications - J. Fang
  • MCS I: Cardiogenic Shock and Temporary Support Devices - N. Uriel
  • MCS II: Durable MCS Selection and Outcomes - N. Uriel
  • MCS III: Adverse Events and Patient Management - J. Rogers
  • Adult Congenital Heart Disease for the HF Specialist - E. Krieger
  • HF and Biomarkers - M. Felker
  • Pericarditis and Myocarditis - A. Anderson
  • HFpEF, Epidemiology, Co-morbidities and Phenomapping - S. Shah
  • HFpEF, Assessment, Treatment and Outcomes - S. Shah
  • Management of Arrhythmias in Heart Failure - J. Cooper
  • Device Therapy in Heart Failure - J. Cooper
  • Q&A – Faculty
  • Acute Decompensated Heart Failure I - G. M. Felker
  • Acute Decompensated Heart Failure II - G. M. Felker
  • Drug Therapy for Heart Failure I - M. Drazner
  • Drug Therapy for Heart Failure II - M. Drazner
  • Assessment of Functional Capacity in HF/CPET - M. Drazner
  • Clinico-pathological Correlates - J. Lomasney
  • Heart Failure Epidemiology and Risk Factors &  - J. Butler; L. Stevenson
 
Accreditation Statement

This HFSA Board Review Course has been designed based on the competencies identified with practice in the area of Advanced Heart Failure and Transplant Cardiology. These competencies include epidemiology, causes and management of patients with HF, management of hospitalized patients, management of comorbidities, cardiac surgery in HF, medical management of the heart transplant patient and patients with mechanical circulatory support, and evaluation and management of patients with pulmonary arterial hypertension.

Physicians

The Heart Failure Society of America is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Failure Society of America designates this live activity for a maximum of 20 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 20 MOC points in the Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty and Accreditor Disclosures
Sean P. Pinney, MD (Program Chair)
Employment: Mt. Sinai Hospitak
Speaker/Honoraria: CareDX
Consultant/Advisory Board: Abbott, Inc.

Akshay Desai, MD , MPH, FHFSA (Program Chair)
Employment: Brigham and Women's Hospital
Research Grant: Novartis
Consultant/Advisory Board: Abbott/St. Jude Medical;
AstraZeneca; Relypsa; Dalcor Pharmaceutical;
Janssen

Allen S. Anderson, MD, FACC, FAHA
Employment: Northwestern University Feinberg School
of Medicine
Research Grant: Abbott
Speaker/Honoraria: Relypsa; Novartis
Consultant/Advisory Board: GE Healthcare

Daniel Burkhoff, MD, PhD
Employment: Cardiovascular Research Foundation
Research Grant: Abiomed
Speaker/Honoraria: Zoll Medical
Ownership Interest: Impulse Dynamics
Consultant/Advisory Board: Corvia Medical; BackBeat
Medical; Impulse Dynamics; Cardiac Implants;
Sensible Medical; Corinnova

Javed Butler, MD, MPH, MBA, FHFSA
Employment: University of Mississippi Medical Center
Consultant/Advisory Board: Amgen; Array;
AstraZeneca; Bayer; Boehringer Ingelheim; Bristol
Meyers Squibb; CVRx; G3 Pharmaceutical; Innolife;
Janssen; Medtronic; Merck; Novartis; Relypsa; Stealth
Peptide; SC Pharma; Vifor; ZS Pharma

Joshua M. Cooper, MD
Employment: Temple University, School of Medicine
Speaker/Honoraria: Medtronic; Boston Scientific; Zoll
Medical
Consultant/Advisory Board: Abbott Medical; Biosense
Webster; Spectranetics

Mark Drazner, MD, FHFSA
Employment: UT Southwestern Medical Center

James C. Fang, MD, FACC, FAHA, FHFSA
Employment: University of Utah
Consultant/Advisory Board: Novartis; Agmen;
Capricor; Johnson & Johnson; AHA; NIH

G. Michael Felker, MD, FHFSA
Employment: Duke University
Research Grant: Amgen; Merck; Cytokinetics
Consultant/Advisory Board: Novartis; Amgen; Roche
Diagnostics; Cytokinetics; Innolife; BMS; EBR
Systems; Medtronic; Cardionoomic; Myokardia

Eric V. Krieger, MD
Employment: University of Washington, Seattle
Children's Hospital
Research Grant: Rare Disease Foundation; American
Heart Association

Jon W. Lomasney, MD
Employment: Northwestern University, Feinberg
School of Medicine
Research Grant: NIH 7888; NIH 5881; AHA 16GRNT
30990033
Speaker/Honoraria: Multiple law firms; medical legal
cases - no product liability case
Consultant/Advisory Board: Sarnoff Cardiovascular
Research Foundation (BOD, not-for-profit)

Anju Nohria, MD, M
Eon W. Lomasney, MDmployment: Brigham and Women's Hospital, Harvard
Medical School
Research Grant: Amgen, Inc.
Consultant/Advisory Board: Takeda Oncology

Jonathan D. Rich, MD, FHFSA
Employment: Northwestern University

Joseph G. Rogers, MD
Employment: Duke University, School of Medicine

Sanjiv J. Shah, MD
Employment: Northwestern University
Research Grant: Actelion; AstraZeneca; Bayer;
ScNovartis
Consultant/Advisory Board: Actelion; Amgen;
AstraZeneca; Bayer; BMS; Boehringer-Ingleheim;
Cardiora; Eisai; Ironwood; Merck; Novartis; Sanofi;
Tenax Therapeutics; United Therapeutics

Nir Uriel, MD, MSc
Employment: University of Chicago
Research Grant: Abbott; Medtronic; Novartis
Consultant/Advisory Board: Abbott; Medtronic

Lynne W. Stevenson, MD
Employment: Vanderbilt University Medical Center
Consultant/Advisory Board: Abbott (unpaid); LiviaNova
(Chair DSMB); Myokardia (unpaid; travel only)
Summary
Availability: On-Demand
Cost: Member: $799.00
Non-Member: $899.00
Credit Offered: 19 CME Credits
19 MOC Points
Recommended
Powered by Oasis.